tbc-11251 has been researched along with Albuminuria in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baelde, HJ; Danser, AHJ; de Vries, R; Garrelds, IM; Mirabito Colafella, KM; Montezano, AC; Neves, KB; Touyz, RM; Uijl, E; van den Meiracker, AH; van Veghel, R; Versmissen, J | 1 |
| Dhaun, N; Goddard, J; MacDougall, M; Melville, V; Towler, JD; Webb, DJ | 1 |
1 trial(s) available for tbc-11251 and Albuminuria
| Article | Year |
|---|---|
What is the best method of proteinuria measurement in clinical trials of endothelin receptor antagonists?
Topics: Albuminuria; Analysis of Variance; Creatinine; Double-Blind Method; Drug Monitoring; Endothelin Receptor Antagonists; Humans; Isoxazoles; Proteinuria; Renal Insufficiency, Chronic; Reproducibility of Results; Thiophenes | 2012 |
1 other study(ies) available for tbc-11251 and Albuminuria
| Article | Year |
|---|---|
Selective ETA vs. dual ETA/B receptor blockade for the prevention of sunitinib-induced hypertension and albuminuria in WKY rats.
Topics: Albuminuria; Animals; Antihypertensive Agents; Arteries; Blood Pressure; Disease Models, Animal; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Epoprostenol; Hypertension; Isoxazoles; Kidney; Male; Oxidative Stress; Pyrimidines; Rats, Inbred WKY; Receptor, Endothelin A; Receptor, Endothelin B; Signal Transduction; Sulfonamides; Sunitinib; Thiophenes | 2020 |